Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02941
Species: Homo sapiens
Position : chr2:234762042-234764060
Year: 2025
Title: Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53/E2F1/FOXM1-axis.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: triple-negative breast carcinoma
PMID:  39736453
MONDO: MONDO:0005494
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: BT-549
CVCL ID: CVCL_1092
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF binding assay; functional perturbation assay
High Throughput Method: H3K27ac ChIP-seq; RNA-seq; DNase-seq
Low Throughput Method: dCas9-KRAB CRISPRi; ChIP-qPCR; dual-luciferase reporter assay; RT-qPCR; Western blot; CRISPRi
About Target Gene
Target gene : HJURP
About TF
TF name : FOXM1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXM1 Cyclin A/B1 associated events during G2/M transition reactome 22
FOXM1 FOXM1 transcription factor network pid 43
FOXM1 Polo-like kinase mediated events reactome 16
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_02939 chr2:234762042-234764060 breast malignant cell triple-negative breast carcinoma
E_02940 chr2:234762042-234764060 breast malignant cell triple-negative breast carcinoma
E_02942 chr2:234762042-234764060 breast malignant cell triple-negative breast carcinoma
Expression of Target Genes for the Enhancer